ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 987

Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention

Candace H. Feldman1, Gregory A. Culley2, Erika Brown3, Chanele R. Assencoa2, LeRoi S. Hicks4 and Daniel H. Solomon3,5, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital,Harvard Medical School, Boston, MA, 2Family Health Center of Worcester, Inc., Worcester, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Division of Hospital Medicine, UMass Memorial Medical Center, Worcester, MA, 5Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: access to care and health disparities, Intervention

  • Tweet
  • Email
  • Print
Session Information

Title: ARHP Education/Community Programs

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Early and sustained access to rheumatology care can improve access to disease-modifying medications and reduce disparities in outcomes. In one state, more than one-half of community health center (CHC) medical directors felt that their predominantly low-income, underserved patients required better access to rheumatology care. We pilot tested an intervention that utilized a patient navigator- a layperson trained to provide a range of education, advocacy and care coordination services- to improve access to rheumatology and musculoskeletal care.  

Methods: We partnered with a CHC that cares for over 30,000 patients each year, 95% with income levels below 200% of poverty. The CHC medical director identified an affiliated community health worker to serve as the patient navigator. We developed a rheumatology/musculoskeletal disease curriculum to train the navigator and provided comprehensive patient resources and pamphlets for distribution. We identified established patients with rheumatic and musculoskeletal diseases by ICD-9 code, and primary care providers (PCPs) confirmed whether each patient would benefit from the navigator’s assistance. All patients requiring a new rheumatology appointment were also referred to the navigator. We conducted semi-structured interviews with patients to assess need and tracked all navigator services provided.

Results: Of the 695 patients initially identified by ICD-9 code with possible rheumatic and musculoskeletal diseases, 125 were referred to the navigator; 29 also required new rheumatology appointments. On average, 5 new referrals (range 2-10) were received weekly. After 3 months, 31 (28%) patients were actively working with the navigator, 81 (72%) patients’ PCPs were actively in communication with the navigator, and 62/81 (77%) of these patients were in the process of being engaged (outreach attempts made or waiting for appointments to be scheduled). Two of the 125 (2%) patients declined participation. Among the 31 actively engaged patients, navigator’s services included direct coordination of appointments and repeated reminders prior to the visit (n=26, 84%), facilitation of communication between providers (n=31, 100%), transportation arrangements (n=7, 23%), financial services including provisions for affordable medications (n=4, 13%), coordination of live interpreters (n=2, 6%), and organization of senior services (n=2, 6%). Of the 29 patients scheduled to see rheumatologists, 14/17 (82%) successfully kept their appointments and 12 appointments are upcoming.

Conclusion: This CHC-based rheumatology navigator pilot demonstrates the feasibility and acceptability of subspecialty navigators to improve access to care for underserved patients. Further research is needed to assess the effectiveness and costs of the patient navigator.


Disclosure:

C. H. Feldman,
None;

G. A. Culley,
None;

E. Brown,
None;

C. R. Assencoa,
None;

L. S. Hicks,
None;

D. H. Solomon,

Lilly, Amgen, CORRONA,

2,

Lilly, Novartis, BMS, Pfizer,

6,

Lilly, BMS, Novartis,

9.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-access-to-subspecialty-care-for-underserved-communities-a-rheumatology-patient-navigator-pilot-intervention/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology